| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/09/1991 | CA1282700C Confectionery delivery system for actives |
| 04/05/1991 | WO1991004752A1 Eye-drops |
| 04/05/1991 | CA2067383A1 Eye-drops |
| 04/04/1991 | WO1991004732A1 Erodible macroporous hydrogel particles and preparation thereof |
| 04/04/1991 | WO1991004319A1 Therapeutic ribozyme compositions and expression vectors |
| 04/04/1991 | WO1991004055A1 Treatment of autoimmune disease |
| 04/04/1991 | WO1991004044A1 Method of administering soluble t4 for treatment of human immunodeficiency virus infection |
| 04/04/1991 | WO1991004043A1 Formulation for soluble st4 for treatment of hiv infection |
| 04/04/1991 | WO1991004039A1 Erection-inducing methods and compositions |
| 04/04/1991 | WO1991004034A1 Topical preparation for treatment of aphthous ulcers and other lesions |
| 04/04/1991 | WO1991004026A1 Drug delivery compositions |
| 04/04/1991 | WO1991004018A1 Magnesium carbonate and oil tableting aid |
| 04/04/1991 | WO1991004010A1 An external analgesic lotion and method of making |
| 04/04/1991 | WO1991002553A3 Transdermal nitroglycerin patch with penetration enhancers |
| 04/04/1991 | WO1991000289A3 Targeted liposomes and methods for liposome-protein coupling |
| 04/04/1991 | WO1991000100A3 Toxin uses |
| 04/04/1991 | CA2066684A1 Therapeutic ribozyme compositions and expression vectors |
| 04/04/1991 | CA2066594A1 Erodible macroporous hydrogel particles and preparation thereof |
| 04/03/1991 | WO1991004751A1 Inhibitor of absorption of digestion product of food and drink |
| 04/03/1991 | EP0420798A1 Antimicrobial compositions |
| 04/03/1991 | EP0420785A2 Stable immunogen composition |
| 04/03/1991 | EP0420722A2 Lipid compounds, derivatives of sphingosines, process for their preparation and their use, especially in cosmetics and in dermopharmaceutics |
| 04/03/1991 | EP0420649A2 Stabilized aqueous formulations of small peptides |
| 04/03/1991 | EP0420049A1 Stabilized leucocyte-interferon |
| 04/03/1991 | EP0419998A2 Use of alkylphosphonic acid derivatives for the treatment of psoriasis |
| 04/03/1991 | EP0419890A2 Stable pharmaceutical formulations for antineoplastic compounds having more than one ethyleneimine group, and method |
| 04/03/1991 | EP0419759A2 Aluminium, magnesium-hydroxy-fatty acid compounds and thermostable lipogels prepared therewith |
| 04/03/1991 | EP0419563A1 Time release protein. |
| 04/03/1991 | EP0419532A1 A pharmaceutical preparation and a conjugate of a bactericide and an antibody directed against plaque forming or caries-inducing bacteria |
| 04/03/1991 | EP0419462A1 Improved immunotoxin therapies utilizing purified ricin a-chain species |
| 04/03/1991 | EP0242380B1 A process for preparing immunogenic complex |
| 04/03/1991 | CN1050373A Process for preparing optically active 2-aryl-alkanoic acid, in particular 2-aryl propionic |
| 04/03/1991 | CN1050327A Protein-containing aqueous solutions |
| 04/03/1991 | CN1050321A Thrombolytic composition containing tissue type plasminogen activator or derivative thereof |
| 04/03/1991 | CA2067353A1 Inhibitor of absorption of digestion product of food and drink |
| 04/03/1991 | CA2026462A1 Tretinoin emulsified cream formulations of improved stability |
| 04/02/1991 | US5004791 Glass fiber sizing composition |
| 04/02/1991 | US5004771 Polyorganosiloxane, alkaline earth metal or alkali organo-siliconate, nonsilicious inorganic filler; storage stability |
| 04/02/1991 | US5004756 Anti-cancer activity potentiator |
| 04/02/1991 | US5004692 Pure DNA segment for producing large quantities of clostridium phospholipase polypeptides |
| 04/02/1991 | US5004651 Of estropipate and tromethamine |
| 04/02/1991 | US5004612 Pharmaceutical compositions comprising esters or amides as active ingredients |
| 04/02/1991 | US5004606 Non-covalent antibody-anthracycline immunocomplexes |
| 04/02/1991 | US5004605 Low pH pharmaceutical compositions of recombinant β-interferon |
| 04/02/1991 | US5004602 Continuous release pharmaceutical compositions formed by freeze drying acetic acid solutions of polylactide |
| 04/02/1991 | US5004601 Low-melting moldable pharmaceutical excipient and dosage forms prepared therewith |
| 04/02/1991 | US5004598 Stable and quick-breaking topical skin compositions |
| 04/02/1991 | US5004595 Multiple encapsulated flavor delivery system and method of preparation |
| 04/02/1991 | US5004593 Hexamethylmelamine formulation exhibiting reduced neurotoxicity |
| 04/02/1991 | CA1282330C Drug depot containing cytostatics |
| 04/02/1991 | CA1282329C Medicament adsorbates with surfactant and their preparation |
| 04/02/1991 | CA1282328C Medicament adsorbates with complex magnesium aluminum silicate and their preparation |
| 04/02/1991 | CA1282327C Slow-release pharmaceutical agent |
| 04/02/1991 | CA1282326C Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient |
| 04/02/1991 | CA1282319C Animal bait |
| 03/30/1991 | WO1991005001A1 Yttrium and rare earth compounds catalyzed lactone polymerization |
| 03/30/1991 | CA2066029A1 Yttrium and rare earth compounds catalyzed lactone polymerization |
| 03/30/1991 | CA2026508A1 Stable immunogen composition for oral administration |
| 03/29/1991 | CA2026149A1 Stabilized aqueous formulations of small peptides |
| 03/29/1991 | CA2024046A1 Stabilized leukocyte-interferons |
| 03/28/1991 | WO1991004745A1 Compositions for cell adhesion inhibition and methods of use |
| 03/28/1991 | CA2067183A1 Compositions for cell adhesion inhibition and methods of use |
| 03/27/1991 | WO1991004733A1 Ibuprofen triturates and topical compositions containing same |
| 03/27/1991 | EP0419254A2 Polyester compositions and organotin esterification catalysts therefor |
| 03/27/1991 | EP0419252A1 Thrombolytic composition containing tissue type plasminogen activator or derivative thereof |
| 03/27/1991 | EP0419251A1 Protein-containing aqueous solutions |
| 03/27/1991 | EP0419165A2 Preservative for ophthalmic solutions |
| 03/27/1991 | EP0419156A2 Bioerodible thermoset elastomers |
| 03/27/1991 | EP0418697A1 Pharmaceutical compositions containing calcitonin |
| 03/27/1991 | EP0418674A1 Pharmaceutical preparations for enhanced absorption of antibacterial compounds |
| 03/27/1991 | EP0418642A1 High-absorbable transvaginal preparation containing biologically active peptides |
| 03/27/1991 | EP0418564A1 Effervescent cold or sinus allergy medicine composition having reduced sodium content |
| 03/27/1991 | EP0418523A1 Amylose-lysozyme hybrid, an activated sugar and processes for producing them |
| 03/27/1991 | EP0418341A1 Percutaneous drug delivery system |
| 03/27/1991 | CA2067131A1 Ibuprofen triturates and topical compositions containing same |
| 03/26/1991 | US5003098 Administering a Myo-Inositol Triphosphate |
| 03/26/1991 | US5002974 Anesthetic/skin moisturizing composition and method of preparing same |
| 03/26/1991 | US5002973 Stabilized sulfite-free catecholamine compositions |
| 03/26/1991 | US5002952 Benzoylurea Antitumor Agents |
| 03/26/1991 | US5002940 Solid drug formulations and stable suspensions |
| 03/26/1991 | US5002938 Fungicide, Steroid, Alcohol and Diol and/or Triol Solvent, Hydroxyalkyl Cellulose |
| 03/26/1991 | US5002930 Protein absorption enhancing agents |
| 03/26/1991 | US5002769 Compositions for the sustained-release of chlorhexidine |
| 03/26/1991 | US5002582 Natural or synthetic resins bonded through latent reactive groups |
| 03/26/1991 | US5002071 Sterilized collagen material for injection in humans |
| 03/26/1991 | CA1282069C Antibody complexes of hapten-modified diagnostic or therapeutic agents |
| 03/26/1991 | CA1282007C Formulations containing azole derivatives, and their use for atraumatic nail removal |
| 03/26/1991 | CA1282006C Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-dihydro 4-oxo-7-(1-piperazinyl)-quinoline-3- carboxylic acid |
| 03/22/1991 | WO1991004058A2 Treatment of conditions and disease |
| 03/22/1991 | WO1991004012A1 Paucilamellar lipid vesicles using charge-localized, single chain, nonphospholipid surfactants |
| 03/22/1991 | CA2042034A1 Treatment of conditions and disease |
| 03/21/1991 | WO1991003510A1 Bioerodible polymers useful for the controlled release of therapeutic agents |
| 03/21/1991 | WO1991003258A1 Immunoliposomes for transmittal of activating signals to cells |
| 03/21/1991 | WO1991003247A1 Dosage form for administering oral hypoglycemic glipizide |
| 03/21/1991 | WO1991003244A1 Composition for percutaneous administration |
| 03/21/1991 | WO1990015586A3 Bioerodible polymers for drug delivery in bone |
| 03/21/1991 | CA2025480A1 Bioerodible thermoset elastomers |
| 03/20/1991 | EP0417930A1 Low-irritative nasal preparation |
| 03/20/1991 | EP0417927A1 Detection and treatment of infections with immunoconjugates |
| 03/20/1991 | EP0417910A2 Method of making highly adsorptive polymers |